Newsroom | 19416 results

DUBLIN--(BUSINESS WIRE)--The "Polymer Extrusion 3D Printing Markets 2025-2034: Analysis and Forecast in the Age of Low-Cost Upstarts" report has been added to ResearchAndMarkets.com's offering. This report represents the latest findings and trends in the polymer extrusion 3D printing market. The accompanying Excel file market database and forecasts reflects the latest impacts from innovations, adoption rates, and challenges by material, segment, application, geography, and vendor. This report e...

DUBLIN--(BUSINESS WIRE)--The "Supplier and Contract Manufacturer Management: Compliance, Qualification & Oversight (Feb 18th - Feb 19th, 2026)" training has been added to ResearchAndMarkets.com's offering. This comprehensive supplier management course is designed to enhance your skills in effectively managing supplier relationships throughout their lifecycle. From supplier identification and qualification to building strong relationships, risk management, continuous assessment, and exit pla...

LYON, Francia--(BUSINESS WIRE)--Fabentech, empresa biofarmacéutica francesa especializada en medidas médicas en respuesta a amenazas biológicas, anunció hoy que ha recibido la autorización de comercialización para Ricimed®, un tratamiento para la intoxicación por ricina. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única versión del texto que tend...

LIONE, Francia--(BUSINESS WIRE)--Fabentech, azienda biofarmaceutica francese specializzata in contromisure mediche contro le minacce biologiche, ha annunciato oggi di aver ricevuto l'autorizzazione alla commercializzazione per Ricimed®, un trattamento contro l'avvelenamento da ricina. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua...

LYON, Frankreich--(BUSINESS WIRE)--Fabentech, ein französisches biopharmazeutisches Unternehmen, das sich auf medizinische Gegenmaßnahmen gegen biologische Bedrohungen spezialisiert hat, gibt heute bekannt, dass es die Marktzulassung für Ricimed® erhalten hat, ein Medikament zur Behandlung von Rizinvergiftungen. Ricimed®, ein Gegenmittel gegen eine der giftigsten natürlichen Substanzen der Welt Zusätzlich zur unterstützenden Behandlung und in schweren Fällen, die eine sofortige Verabreichung er...

LYON, France--(BUSINESS WIRE)--Fabentech, société biopharmaceutique française spécialisée dans les contre-mesures médicales de lutte contre les menaces biologiques, annonce aujourd'hui avoir obtenu l'autorisation de mise sur le marché de Ricimed®, un traitement contre l'intoxication à la ricine. Ricimed®, un antidote contre l'une des substances naturelles les plus toxiques au monde En complément des soins de soutien, et dans les conditions graves nécessitant une administration immédiate, Ricime...

LYON, Frankrijk--(BUSINESS WIRE)--Fabentech, een Frans biofarmaceutisch bedrijf gespecialiseerd in medische tegenmaatregelen tegen biologische bedreigingen, maakte vandaag bekend dat het bedrijf een vergunning werd verleend om Ricimed® op de markt te brengen, een behandeling tegen ricinevergiftiging. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been selected as one of 10 companies awarded contracts under the Defense Microelectronics Activity’s (DMEA) Advanced Technology Support Program V (ATSP V). The 10-year, government-wide, multiple award Indefinite Delivery/Indefinite Delivery (IDIQ) contract vehicle has a ceiling of $25.35 billion, to rapidly provide engineering solutions for electronics and software problems. Under the contract, Battelle will deliver engineering development capabilit...

CHESAPEAKE, Va.--(BUSINESS WIRE)--Blackhawk today announced it won the contract to supply the Bundeswehr Holster Carry System for the German armed forces....

DUBLIN--(BUSINESS WIRE)--The "Medium & Large Calibre Military Ammunition - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. The global ammunition market is currently shaped by two key factors: the war in Ukraine and the urgency for increased production. The conflict has dramatically heightened ammunition consumption, revealing that Western nations were unprepared for high-intensity warfare against peer adversaries. In particular, European c...